SCHEMBL1139009

SCHEMBL1139009

N#Cc1ccc(OCCCCCC(=O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.71
HDAC1 Q13547 2/20 0.65
HDAC2 Q92769 2/20 0.65
MMP3 P08254 2/20 0.62
PPARA Q07869 4/20 0.58
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
ALB P02768 1/20 0.55
MMP1 P03956 1/20 0.54
MMP9 P14780 1/20 0.54
MMP13 P45452 1/20 0.54
PLA2G4B P0C869 4/20 0.52
HRH3 Q9Y5N1 1/20 0.51
SERPINE1 P05121 1/20 0.51
FFAR1 O14842 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5516422 1.00 MMP2 (0.71) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL3952240 1.00 MMP2 (0.71) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL4614541 0.98 MMP2 (0.73) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL7520274 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL13862226 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL8657014 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL5097470 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL6252232 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL9128810 0.95 MMP2 (0.80) MMP2HDAC1HDAC2MMP3PPARA
SCHEMBL4273348 0.94 MMP2 (0.82) MMP2HDAC1HDAC2MMP3PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253160-B1 Electrophotographic encapsulated toner particles and method for making them CANON KK (JP) 2011-02-23 EP disclosed
US-7638590-B2 Polyhydroxyalkanoate having amide, sulfonic acid or sulfonate ester group, charge control agent and toner CANON KABUSHIKI KAISHA (JP) 2009-12-29 US disclosed
US-7615233-B2 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KABUSHIKI KAISHA (JP) 2009-11-10 US disclosed
US-7527809-B2 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof CANON KABUSHIKI KAISHA (JP) 2009-05-05 US disclosed
EP-1275378-B1 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KK (JP) 2009-04-15 EP disclosed
US-20090029423-A1 METHOD FOR SEPARATING TARGET COMPONENT CANON KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
US-7459517-B2 Polyhydroxyalkanoate, process for preparing the same, and resin composition containing the polyhydroxyalkanoate CANON KABUSHIKI KAISHA (JP) 2008-12-02 US disclosed
EP-1113033-B1 Polyhydroxyalkanoate CANON KK (JP) 2008-11-26 EP disclosed
US-7452960-B2 Polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2008-11-18 US disclosed
US-7425432-B2 Polyhydroxy alkanoate copolymer including within molecule unit having vinyl group or carboxyl group in side chain, and producing method therefor CANON KABUSHIKI KAISHA (JP) 2008-09-16 US disclosed
US-20020081646-A1 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material CANON KABUSHIKI KAISHA (JP) 2002-06-27 US disclosed
US-20020065389-A1 Polyhydroxyalkanoate containing 3-hydroxythienylalkanoic acid as monomer unit and method for producing the same CANON KABUSHIKI KAISHA (JP) 2002-05-30 US disclosed
EP-1201763-A2 Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material CANON KABUSHIKI KAISHA (JP) 2002-05-02 EP disclosed
EP-1188782-A2 Polyhydroxyalkanoate and manufacturing method thereof CANON KABUSHIKI KAISHA (JP) 2002-03-20 EP disclosed
US-20020022253-A1 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2002-02-21 US disclosed
US-20010029039-A1 Polyhydroxyalkanoates and method of producing them by utilizing mircroorganisms CANON KABUSHIKI KAISHA (JP) 2001-10-11 US disclosed
EP-1130043-A2 Polyhydroxylalkanoate containing 3-hydroxythienylalkanoic acid as monomer unit and method for producing the same CANON KABUSHIKI KAISHA (JP) 2001-09-05 EP disclosed
EP-1130042-A2 Polyhydroxyalkanoate containing 3-hydroxybenzoylalkanoic acid as monomer unit, and method for producing the same CANON KABUSHIKI KAISHA (JP) 2001-09-05 EP disclosed
EP-1118629-A2 Polyhydroxyalkanoates and method of producing them by utilizing microorganisms CANON KABUSHIKI KAISHA (JP) 2001-07-25 EP disclosed
EP-1113033-A2 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2001-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020081646-A1 Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material FASN, FFAR1, ACADM MMP2 1605/4885HDAC1 3168/4885HDAC2 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.